AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21062392
Drug: Naftopidil 75
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 75 mg/day for 6 weeks
Trial: 19926556
Drug: Pharmacist‐provided intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist‐provided intervention to improve heart failure medication adherence
Trial: 10374274
Drug: Fluconazole (Flu)
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole (Flu) 200-400 mg daily for 1-8 weeks
Trial: 10374274
Drug: Ketoconazole (Keto)
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole (Keto) 400 mg daily for 1-8 weeks
Trial: 10374274
Drug: Fluconazole (Flu)
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole (Flu) in open trial (150 mg single dose for fungal vaginitis)
Trial: 3330526
Drug: AQ‐A 39
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQ‐A 39 (falipamil), 2 mg kg‐1
Trial: 3330526
Drug: Propranolol, 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 0.1 mg kg‐1
Trial: 10895746
Drug: Triamcinolone 40
RxNorm normalized name: TRIAMCINOLONE 40MG/ML INJ,SUSP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamcinolone 40 mg
Trial: 31164277
Drug: 3-weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly cisplatin
Trial: 31364232
Drug: L-NMMA +
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA + Teduglutide
Trial: 31364232
Drug: L-NMMA +
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA + Placebo
Trial: 25769495
Drug: Tumour necrosis
RxNorm normalized name: Tumour necrosis factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumour necrosis factor inhibitor strategy
Trial: 25769495
Drug: Combined disease
RxNorm normalized name: LYME DISEASE VACCINE
DrugBank: Lyme disease vaccine (recombinant OspA) (DB00045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined disease modifying drug strategy
Trial: 23394263
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy (ertapenem 1 g per day for 3 days, followed by oral levofloxacin 500 mg per day and metronidazole 1.5 g per day for 7 days)
Trial: 17154642
Drug: Methotrexate therapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate therapy (starting dose of 10-15 mg/m2/week orally, increased to 15-20 mg/m2/week parenterally)
Trial: 17154642
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with methotrexate and an NSAID
Trial: 17154642
Drug: Daily folate
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily folate supplementation
Trial: 12580112
Drug: Effervescent tablet
RxNorm normalized name: Pain Relief Effervescent Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent tablet of potassium chloride (2 g)
Trial: 12580112
Drug: Common tablet
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common tablet of potassium chloride (2 g)
Trial: 9240183
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 2% lignocaine gel for 25 min
Trial: 9240183
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 2% lignocaine gel for 15 min
Trial: 9240183
Drug: Plain lubricating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain lubricating gel for 5 min
Trial: 9240183
Drug: Plain lubricating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain lubricating gel for 25 min
Trial: 9240183
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 2% lignocaine gel for 5 min
Trial: 31987331
Drug: Supplemental CoQ10
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supplemental CoQ10 (300 mg/kg)
Trial: 31987331
Drug: Supplemental CoQ10
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supplemental CoQ10 (600 mg/kg)
Trial: 31987331
Drug: Supplemental CoQ10
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supplemental CoQ10 (900 mg/kg)
Trial: 15377061
Drug: Combination dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination dietary supplement
Trial: 8046120
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg capsules)
Trial: 8046120
Drug: Nitrendipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (5 mg from vial)
Trial: 29483185
Drug: Basal-Bolus Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal-Bolus Insulin
Trial: 22739369
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplements (5 g/d, 2 g EPA, 1 g DHA)
Trial: 22739369
Drug: Corn/soy oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn/soy oil (PL) (5 g/d)
Trial: 20604814
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with 80 mg Tokyo strain BCG instillation once weekly for eight consecutive weeks.
Trial: 20604814
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with four additional BCG instillations after achieving CR.
Trial: 20604814
Drug: Observation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation group (control) after induction therapy.
Trial: 20604814
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with BCG.
Trial: 20604814
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with BCG.
Trial: 20604814
Drug: Induction and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction and maintenance therapy with BCG.
Trial: 16554456
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/d) for 18 days
Trial: 16554456
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg/d) coadministered in the last 4 study days
Trial: 16554456
Drug: Paroxetine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine and Aspirin combination
Trial: 10670114
Drug: rocuronium 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium 0.05 mg/kg
Trial: 10670114
Drug: vecuronium 0.007
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vecuronium 0.007 mg/kg
Trial: 9078354
Drug: IVIg (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIg (500 mg/kg/month)
Trial: 1856146
Drug: Netilmicin once
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin once daily (6.6 mg/kg)
Trial: 1856146
Drug: Amikacin once
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin once daily (14.5 mg/kg)
Trial: 1856146
Drug: Netilmicin thrice
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin thrice daily (tid)
Trial: 1856146
Drug: Netilmicin twice
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin twice daily (bd)
Trial: 1856146
Drug: Amikacin twice
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin twice daily (bd)
Trial: 24698485
Drug: Darunavir 800
RxNorm normalized name: darunavir 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir 800 mg plus ritonavir 100 mg once daily
Trial: 19317821
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin (s.c.)
Trial: 15258698
Drug: Oral cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cisplatin (10‐30 mg/m2)
Trial: 15258698
Drug: Intravenous cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisplatin (30‐min infusions)
Trial: 15258698
Drug: Oral cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cisplatin
Trial: 10561263
Drug: Accelerated hyperfractionated
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated hyperfractionated radiation therapy (ACC HFX RT) with 54 Gy in 36 fractions over 18 treatment days plus concurrent daily carboplatin/etoposide (CE) (group 1, n = 55)
Trial: 10561263
Drug: Cisplatin/etoposide (PE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin/etoposide (PE) chemotherapy alone (group 2, n = 54)
Trial: 10150495
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 micrograms) twice daily with HFA134a
Trial: 10150495
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) (250 micrograms) twice daily with HFA134a
Trial: 2285609
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 30 mg/day + Bromocriptine (B) 5 mg/day
Trial: 2285609
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 30 mg/day + Placebo
Trial: 7029648
Drug: PGE2 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 0.04 mg four times daily
Trial: 7029648
Drug: PGE2 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 0.25 mg four times daily
Trial: 7029648
Drug: PGE2 0.5
RxNorm normalized name: PGE2 0.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 0.5 mg four times daily
Trial: 7029648
Drug: ASA (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA (650 mg four times daily)
Trial: 30280324
Drug: Whitening strips
RxNorm normalized name: Teeth Whitener Dental Film [LUMINEUX WHITENING STRIPS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whitening strips (White Strips, Oral-b)
Trial: 21936957
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of skill-building and price reductions
Trial: 18347178
Drug: Tamoxifen-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen-based therapy (ABCSG Trial 05)
Trial: 18347178
Drug: Tamoxifen-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen-based therapy (ABCSG Trial 06)
Trial: 10761165
Drug: OROS (methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS (methylphenidate HCl) 18 mg qd
Trial: 10761165
Drug: Sustained-release (SR)
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release (SR) methylphenidate 20 mg qd
Trial: 10761165
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) formulation (three 5 mg doses every 4 hours)
Trial: 8598756
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐oestradiol 200 micrograms daily for 3 months, then 3 months with added cyclical dydrogesterone 10mg daily for 12 days each month
Trial: 8598756
Drug: Placebo patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patches and tablets according to the same regimen
Trial: 3903070
Drug: High-dose methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylprednisolone (1000 mg bolus and 1000 mg daily for 10 days)
Trial: 3903070
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose methylprednisolone (100 mg bolus and 100 mg daily for 10 days)
Trial: 23146983
Drug: Citalopram, 20
RxNorm normalized name: Escitalopram, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram, 20 mg/d for 3 months
Trial: 18819472
Drug: Oral tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tacrolimus
Trial: 15497661
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Osalen 10 mg tablets)
Trial: 15497667
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (originator product)
Trial: 8318320
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% infused at 5 ml h‐1
Trial: 26493601
Drug: Family-based cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based cognitive-behavioral therapy for chronic pain
Trial: 18503493
Drug: Perceived barriers
RxNorm normalized name: Valiant Barrier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceived barriers to physical activity (e.g., poor health, fear, negative experiences, lack of knowledge)
Trial: 9689428
Drug: Ranitidine 4
RxNorm normalized name: ranitidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 4 x 150 mg or tetracycline 4 x 500 mg or metronidazole 3 x 250 mg for 2 weeks
Trial: 2543309
Drug: Syo‐saiko‐to (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syo‐saiko‐to (7.5 g/day)
Trial: 2543309
Drug: Conventional medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medicine (control group)
Trial: 30738342
Drug: Expectation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectation of teaching with unlimited motor preparation
Trial: 30738342
Drug: Expectation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectation of teaching with limited motor preparation
Trial: 30738342
Drug: Expectation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectation of being tested with unlimited motor preparation
Trial: 30738342
Drug: Expectation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectation of being tested with limited motor preparation
Trial: 26022817
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg, n = 519
Trial: 23651076
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose (S)
Trial: 23651076
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral sucrose and facilitated tucking (SFT)
Trial: 19162420
Drug: Non-olanzapine antipsychotic
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-olanzapine antipsychotic
Trial: 15231903
Drug: Chelation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chelation therapy with succimer
Trial: 8150546
Drug: Amlodipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2.5 to 10 mg) once daily
Trial: 8150546
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) (25 to 100 mg) daily
Trial: 8150546
Drug: Amlodipine-atenolol combination
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine-atenolol combination therapy
Trial: 8150546
Drug: HCTZ-atenolol combination
RxNorm normalized name: amiloride / atenolol / hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ-atenolol combination therapy
Trial: 28857388
Drug: Metformin extended-release
RxNorm normalized name: metformin Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin extended-release (XR) 2000 mg once daily
Trial: 28857388
Drug: Metformin immediate-release
RxNorm normalized name: metformin Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin immediate-release (IR) 1000 mg twice daily
Trial: 18585701
Drug: Rosuvastatin 20
RxNorm normalized name: rosuvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 20 mg/day
Trial: 12814444
Drug: Moxonidine sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine sustained release (1.5 mg o.d.)
Trial: 6342837
Drug: Metoprolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (15 mg i.v. + 200 mg/day) for 90 days
Trial: 31124367
Drug: Liberal perioperative
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liberal perioperative oxygen therapy (≥80% oxygen)
Trial: 31124367
Drug: Routine titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine titration of inspired oxygen
Trial: 31124367
Drug: Minimising oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimising oxygen administration
Trial: 31124367
Drug: Maximising oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximising oxygen administration
Trial: 25596881
Drug: Levodopa treatment
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa treatment initiated after baseline assessment
Trial: 23980876
Drug: Intratumoral plasmid
RxNorm normalized name: plasmin
DrugBank: Fibrinolysin (DB05254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intratumoral plasmid AMEP electrotransfer (1 and 2 mg DNA)
Trial: 19411053
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (n = 50) watched 4 weekly episodes of the cooking show, Good Grubbin'
Trial: 19411053
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 51) watched 4 weekly episodes on sleep disorders
Trial: 17724537
Drug: Therapeutic guidelines
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic guidelines for the treatment of nosocomial pneumonia (group with intervention)
Trial: 12040756
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment group (no HBO)
Trial: 9808859
Drug: Sublingual glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual glyceryl trinitrate (GTN) 800 microg
Trial: 2539204
Drug: Imipramine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (2.5 mg/kg/day)
Trial: 2539204
Drug: Tyrosine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyrosine (100 mg/kg/day)
Trial: 6185089
Drug: Topical arabinosyladenine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical arabinosyladenine monophosphate (ara-AMP)
Trial: 21203735
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent sodium ascorbate gel combined with a surfactant
Trial: 21203735
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent carbamide peroxide without an antioxidant agent
Trial: 28240687
Drug: Liberal transfusion
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liberal transfusion strategy (hemoglobin threshold < 9 g/dL)
Trial: 28240687
Drug: Restrictive transfusion
RxNorm normalized name: Pinus spp. wood destructive distillate
DrugBank: Pine tar (DB15840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive transfusion strategy (hemoglobin threshold < 7 g/dL)
Trial: 23880333
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) group, 8 weeks duration, 1 session per week, 100 minutes per session
Trial: 17499084
Drug: Self-administered ERP
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered ERP
Trial: 17499084
Drug: Therapist-administered ERP
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist-administered ERP
Trial: 15240647
Drug: Isoflavonoids (114
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavonoids (114 mg/d)
Trial: 11802014
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice a day for 2 months